Presage’s device would allow oncologists to test potentially harmful compounds in tiny amounts before giving patients a full dose.
Portable diagnostic tools could offer a better outlook for TB patients.
Amgen and Genzyme are pursuing disruptive ways of making biological drugs.
In 2012, genomics tiptoed into the doctor’s office, gene therapy rose again, and man and machine united.
It’s hard to get straightforward health guidance from personal genome tests, which are banned in some places. But one way to make them more meaningful is to let more people buy them.
Proterro has received $3.5 million in funding to scale up its low-cost approach.
Devices from two startups could be used to treat people with anxiety disorders—and one of the devices may eventually diagnose pain.
With twice as many electrodes in her brain as previous study participants, a paralyzed woman can move a robotic arm with unprecedented flexibility.
Nearly 1.5 million people die from tuberculosis every year, even though most cases can be cured with routine antibiotic treatments. One country’s fight to get the ancient scourge under control has an unlikely hero: a simple diagnostic test.
The chemical-sniffing setup will send data to the Web so doctors and patients can get a better sense of what causes attacks.